Abbott Continues Acquisition Streak With Solvay Deal.
Abbott Laboratories' (ABT) $6.6 billion purchase of Solvay SA's (SVYSY) drug business continues a busy stretch of acquisitions for Abbott and bolsters the company's reputation of looking outside the company for growth.
Full Story